Replies to post #379052 on Anavex Life Sciences Corp (AVXL)

[tradeherpete]

Come on, you made a prediction, don't go back on your word.

And in your defense, I can't believe I'm doing this.

Primary Outcome Measures :
ADAS-Cog (Alzheimer Disease Assessment Scale-Cognition) [ Time Frame: 48 weeks ]
Reduction in cognitive decline assessed from baseline over 48 weeks with ANAVEX2-73 compared to placebo using the Alzheimer Disease Assessment Scale-Cognition (ADAS-Cog)

ADCS-ADL (Activities of Daily Living) [ Time Frame: 48 weeks ]
Reduction in decline of the ability to perform daily activities assessed from baseline over 48 weeks with ANAVEX2-73 compared to placebo using the Activities of Daily Living Scale (ADCS-ADL

)
https://clinicaltrials.gov/ct2/show/NCT03790709?term=Anavex&draw=2&rank=6